tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
IMAB is currently covered by 3 analysts with an average price target of $14.48. This is a potential upside of $10.58 (271.28%) from yesterday's end of day stock price of $3.9.
I-Mab's activity chart (see below) currently has 16 price targets and 33 ratings on display. The stock rating distribution of IMAB is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 52.57% with an average time for these price targets to be met of 139 days.
Highest price target for IMAB is $7, Lowest price target is $5, average price target is $5.67.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 09-Jul-2025. First documented stock forecast 11-Feb-2020.
Currently out of the existing stock ratings of IMAB, 12 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$0.62 (14.16%)
$5
2 months 2 days ago
(09-Jul-2025)
3/7 (42.86%)
$2.69 (116.45%)
72
Buy
$7
$2.62 (59.82%)
5 months 7 days ago
(04-Apr-2025)
1/5 (20%)
$6.32 (929.41%)
85
Buy
$5
$0.62 (14.16%)
$16
1 years 6 months 30 days ago
(12-Feb-2024)
2/2 (100%)
$3.2 (177.78%)
314
Buy
2 years 6 days ago
(05-Sep-2023)
3/4 (75%)
$13.97 (18.37%)
133
Buy
$35
2 years 5 months 9 days ago
(03-Apr-2023)
1/4 (25%)
$26.73 (323.22%)
91
What is IMAB (I-Mab) average time for price targets to be met?
Which analyst has the current highest performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the current lower performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the most public recommendations on IMAB (I-Mab)?
Which analyst is the currently most bullish on IMAB (I-Mab)?
Which analyst is the currently most reserved on IMAB (I-Mab)?
